Journal
ACS MEDICINAL CHEMISTRY LETTERS
Volume 10, Issue 11, Pages 1512-1517Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.9b00409
Keywords
Drug discovery; photocycloaddition; sp(3)-rich scaffolds; hit and lead generation
Categories
Funding
- Engineering and Physical Sciences Research Council [EP/P013341/1]
- EPSRC [EP/P013341/1] Funding Source: UKRI
Ask authors/readers for more resources
Pressure on researchers to deliver new medicines to the patient continues to grow. Attrition rates in the research and development process present a significant challenge to the viability of the current model of drug discovery. Analysis shows that increasing the three-dimensionality of potential drug candidates decreases the risk of attrition, and it is for this reason many workers have taken a new look at the power of photochemistry, in particular photocycloadditions, as a means to generate novel sp(3)-rich scaffolds for use in drug discovery programs. The viability of carrying out photochemical reactions on scale is also being addressed by the introduction of new technical developments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available